Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
What We Manufacture
Anti-inflammatory tablets span two major pharmacological classes — NSAIDs for mild-to-moderate inflammation and corticosteroids for severe inflammatory and autoimmune conditions. Our range covers both categories in multiple strengths and release formulations.
Non-steroidal anti-inflammatory drugs for musculoskeletal pain, arthritis, sports injuries and inflammatory conditions.
Oral corticosteroids for systemic anti-inflammatory and immunosuppressive therapy.
Why 9M India
Corticosteroid tablets are low-dose, highly potent drugs requiring exceptional content uniformity — a 4mg Dexamethasone tablet must deliver between 3.8mg and 4.2mg per unit across thousands of tablets in a batch. 9M India's validated low-dose tablet manufacturing processes, with in-process content uniformity testing by HPLC, ensure batch-to-batch consistency for corticosteroid formulations.
Dissolution testing · Disintegration · Hardness · Friability · Assay (HPLC) · Content uniformity · Related substances · Microbiological limits — all tested in our in-house analytical laboratory. Certificate of Analysis issued from our own facility.
Manufacturing Licence · DCGI product approvals · WHO-GMP Certificate · COA · COC · Stability data (ICH aligned) — pre-prepared and available within 24 hours for tender submission, export registration or CDMO due diligence.
Who We Supply
Government & institutional buyers
Government hospital formularies, NHM, rheumatology and orthopaedics programmes — corticosteroids and NSAIDs are standard formulary items across all levels of the government health system.
Domestic pharma brands (3PM/Private Label)
Domestic pharma brands manufacturing anti-inflammatory tablets through 9M India — complete capability from Ibuprofen 200mg through to Methylprednisolone 16mg.
International export buyers
All export markets — musculoskeletal conditions and inflammatory diseases drive sustained anti-inflammatory tablet demand across Africa, the Middle East and South-East Asia.
Share your molecule, strength and target market. We confirm availability and documentation within 24 hours.
WHO-GMP
Certified Facility
In-House QC
Contract &
3PM Available
DCGI
Approved
Therapeutic Categories
Our tablet portfolio covers the therapeutic areas most demanded across domestic institutional supply, generic pharma distribution and international export programmes.